Literature DB >> 16118161

Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.

Christiane K Kuhl1, Hans H Schild, Nuschin Morakkabati.   

Abstract

PURPOSE: To investigate prospectively the trade-off between temporal and spatial resolution in dynamic contrast material-enhanced bilateral magnetic resonance (MR) imaging of the breast.
MATERIALS AND METHODS: Informed consent and institutional review board approval were obtained. An intraindividual comparative study was performed in 30 patients (mean age, 53 years; age range, 27-70 years) with a total of 54 enhancing lesions (28 benign and 26 malignant) who underwent dynamic MR imaging of the breast twice, once with a standard dynamic protocol (256 x 256 matrix, 69 seconds per acquisition) and once on a separate day with a modified dynamic protocol (400 x 512 matrix, 116 seconds per acquisition). Systematic qualitative analysis of morphologic features and region-of-interest-based analysis of enhancement kinetics were performed.
RESULTS: A statistically significant difference (generalized linear modeling) in enhancement rates of benign versus malignant lesions was lost when moving from the standard to the modified dynamic protocol. Kinetic information on signal intensity time course patterns was preserved. Delineation of lesion margins and internal architecture was clearly superior with the modified dynamic protocol, which allowed identification of lesion features associated with high positive predictive value or high negative predictive value for breast cancer. Ten benign lesions classified as Breast Imaging Reporting and Data System (BI-RADS) category 3 with the standard protocol were correctly downgraded to BI-RADS category 2 with the modified protocol owing to visualization of internal septations. Thirteen malignant lesions categorized as BI-RADS category 3 or 4 with the standard protocol were correctly upgraded to BI-RADS category 4 or 5 with the modified protocol owing to visualization of spicules or rim enhancement. Receiver operating characteristic analysis revealed a significantly larger area under the curve for results obtained with the modified dynamic protocol.
CONCLUSION: Increased spatial resolution significantly improves diagnostic confidence and accuracy at dynamic MR imaging, even if this improvement occurs at the expense of temporal resolution. Loss of kinetic information regarding enhancement rates proved to be not diagnostically relevant because enhancement rates showed broad overlap between benign and malignant lesions and were therefore of only limited diagnostic use in the individual patient. Kinetic information regarding time course pattern was preserved and confirmed as having high specificity and high positive predictive value.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16118161     DOI: 10.1148/radiol.2363040811

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  78 in total

Review 1.  Pearls and pitfalls in breast MRI.

Authors:  I Millet; E Pages; D Hoa; S Merigeaud; F Curros Doyon; X Prat; P Taourel
Journal:  Br J Radiol       Date:  2011-11-29       Impact factor: 3.039

2.  Non-contrast enhanced MRI for evaluation of breast lesions: comparison of non-contrast enhanced high spectral and spatial resolution (HiSS) images versus contrast enhanced fat-suppressed images.

Authors:  Milica Medved; Xiaobing Fan; Hiroyuki Abe; Gillian M Newstead; Abbie M Wood; Akiko Shimauchi; Kirti Kulkarni; Marko K Ivancevic; Lorenzo L Pesce; Olufunmilayo I Olopade; Gregory S Karczmar
Journal:  Acad Radiol       Date:  2011-10-01       Impact factor: 3.173

3.  [Functional and molecular imaging of breast tumors].

Authors:  K Pinker; P Brader; G Karanikas; K El-Rabadi; W Bogner; S Gruber; M Reisegger; S Trattnig; T H Helbich
Journal:  Radiologe       Date:  2010-11       Impact factor: 0.635

4.  Feasibility of high temporal resolution breast DCE-MRI using compressed sensing theory.

Authors:  Haoyu Wang; Yanwei Miao; Kun Zhou; Yanming Yu; Shanglian Bao; Qiang He; Yongming Dai; Stephanie Y Xuan; Bisher Tarabishy; Yongquan Ye; Jiani Hu
Journal:  Med Phys       Date:  2010-09       Impact factor: 4.071

5.  Contrast-enhanced dedicated breast CT: initial clinical experience.

Authors:  Nicolas D Prionas; Karen K Lindfors; Shonket Ray; Shih-Ying Huang; Laurel A Beckett; Wayne L Monsky; John M Boone
Journal:  Radiology       Date:  2010-09       Impact factor: 11.105

6.  A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settings.

Authors:  Luminita A Tudorica; Karen Y Oh; Nicole Roy; Mark D Kettler; Yiyi Chen; Stephanie L Hemmingson; Aneela Afzal; John W Grinstead; Gerhard Laub; Xin Li; Wei Huang
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

7.  Potential of computer-aided diagnosis of high spectral and spatial resolution (HiSS) MRI in the classification of breast lesions.

Authors:  Neha Bhooshan; Maryellen Giger; Milica Medved; Hui Li; Abbie Wood; Yading Yuan; Li Lan; Angelica Marquez; Greg Karczmar; Gillian Newstead
Journal:  J Magn Reson Imaging       Date:  2013-09-10       Impact factor: 4.813

8.  Preliminary experience using dynamic MRI at 3.0 Tesla for evaluation of soft tissue tumors.

Authors:  Michael Yong Park; Won-Hee Jee; Sun Ki Kim; So-Yeon Lee; Joon-Yong Jung
Journal:  Korean J Radiol       Date:  2012-12-28       Impact factor: 3.500

9.  Dynamic contrast-enhanced MRI of the breast: quantitative method for kinetic curve type assessment.

Authors:  Riham H El Khouli; Katarzyna J Macura; Michael A Jacobs; Tarek H Khalil; Ihab R Kamel; Andrew Dwyer; David A Bluemke
Journal:  AJR Am J Roentgenol       Date:  2009-10       Impact factor: 3.959

10.  Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging.

Authors:  Ka-Loh Li; Savannah C Partridge; Bonnie N Joe; Jessica E Gibbs; Ying Lu; Laura J Esserman; Nola M Hylton
Journal:  Radiology       Date:  2008-07       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.